Copper(II) Complexes with Isomeric Morpholine-Substituted 2-Formylpyridine Thiosemicarbazone Hybrids as Potential Anticancer Drugs Inhibiting Both Ribonucleotide Reductase and Tubulin Polymerization: The Morpholine Position Matters

Miljan N. M. Milunovic,Katerina Ohui,Iuliana Besleaga,Tatsiana V. Petrasheuskaya,Orsolya Dömötör,Éva A. Enyedy,Denisa Darvasiova,Peter Rapta,Zuzana Barbieriková,Daniel Vegh,Szilárd Tóth,Judit Tóth,Nóra Kucsma,Gergely Szakács,Ana Popović-Bijelić,Ayesha Zafar,Jóhannes Reynisson,Anatoly D. Shutalev,Ruoli Bai,Ernest Hamel,Vladimir B. Arion
DOI: https://doi.org/10.1021/acs.jmedchem.4c00259
IF: 8.039
2024-05-22
Journal of Medicinal Chemistry
Abstract:The development of copper(II) thiosemicarbazone complexes as potential anticancer agents, possessing dual functionality as inhibitors of R2 ribonucleotide reductase (RNR) and tubulin polymerization by binding at the colchicine site, presents a promising avenue for enhancing therapeutic effectiveness. Herein, we describe the syntheses and physicochemical characterization of four isomeric proligands H(2)L^(3)-H(2)L^(6), with the methylmorpholine substituent at pertinent positions of the pyridine...
chemistry, medicinal
What problem does this paper attempt to address?